JP2020520917A5 - - Google Patents

Download PDF

Info

Publication number
JP2020520917A5
JP2020520917A5 JP2019563463A JP2019563463A JP2020520917A5 JP 2020520917 A5 JP2020520917 A5 JP 2020520917A5 JP 2019563463 A JP2019563463 A JP 2019563463A JP 2019563463 A JP2019563463 A JP 2019563463A JP 2020520917 A5 JP2020520917 A5 JP 2020520917A5
Authority
JP
Japan
Prior art keywords
positively charged
gly
botulinum toxin
pharmaceutical composition
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019563463A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020520917A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/033397 external-priority patent/WO2018213710A1/en
Publication of JP2020520917A publication Critical patent/JP2020520917A/ja
Publication of JP2020520917A5 publication Critical patent/JP2020520917A5/ja
Pending legal-status Critical Current

Links

JP2019563463A 2017-05-18 2018-05-18 頸部ジストニアの治療方法 Pending JP2020520917A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762508324P 2017-05-18 2017-05-18
US62/508,324 2017-05-18
PCT/US2018/033397 WO2018213710A1 (en) 2017-05-18 2018-05-18 Methods of treatment for cervical dystonia

Publications (2)

Publication Number Publication Date
JP2020520917A JP2020520917A (ja) 2020-07-16
JP2020520917A5 true JP2020520917A5 (https=) 2021-07-26

Family

ID=64274745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019563463A Pending JP2020520917A (ja) 2017-05-18 2018-05-18 頸部ジストニアの治療方法

Country Status (13)

Country Link
US (3) US20200179498A1 (https=)
EP (1) EP3624819A4 (https=)
JP (1) JP2020520917A (https=)
KR (2) KR102777928B1 (https=)
CN (1) CN110996979A (https=)
AU (2) AU2018270092C1 (https=)
BR (1) BR112019024082A2 (https=)
CA (1) CA3064070A1 (https=)
CO (1) CO2019014212A2 (https=)
MX (1) MX2019013716A (https=)
PH (1) PH12019502578A1 (https=)
RU (1) RU2019141383A (https=)
WO (1) WO2018213710A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2490986T1 (sl) * 2009-10-21 2018-12-31 Revance Therapeutics, Inc. Metode in sistemi za prečiščenje nekompleksiranega nevrotoksina botulina
WO2019046311A1 (en) 2017-08-28 2019-03-07 Revance Therapeutics, Inc. TRANSMUCOSAL COMPOSITIONS OF BOTULINUM TOXIN, KITS AND METHODS FOR TREATING BLADDER DISORDERS
AU2021360788A1 (en) * 2020-10-13 2023-06-01 Revance Therapeutics, Inc. Methods for treating cervical dystonia
AU2022223782A1 (en) * 2021-02-21 2023-09-21 Revance Therapeutics, Inc. Methods of and compositions for treatment of upper limb spasticity
WO2025059665A1 (en) 2023-09-15 2025-03-20 Revance Therapeutics, Inc. Serial treatment with botulinum toxin for cervical dystonia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8557256B2 (en) * 1993-12-28 2013-10-15 Allergan, Inc. Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
TW574036B (en) * 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin
BRPI0508410B8 (pt) * 2004-03-03 2021-05-25 Revance Therapeutics Inc composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
HUE037595T2 (hu) * 2008-12-31 2018-09-28 Revance Therapeutics Inc Injektálható botulinum toxin készítmények
IL268980B (en) * 2009-06-25 2022-09-01 Revance Therapeutics Inc Albumin-free botulinum toxin formulations
US8147848B2 (en) * 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
LT2661276T (lt) * 2011-01-07 2017-12-11 Revance Therapeutics, Inc. Paviršinio naudojimo kompozicija, apimanti botulino toksiną ir dažą
EP2734224A1 (en) * 2011-07-20 2014-05-28 Allergan, Inc. Botulinum toxins for use in a method for treatment of adipose deposits
EP3368071B1 (en) 2015-10-29 2022-01-26 ReVance Therapeutics, Inc. Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect
CA3081596A1 (en) * 2017-11-03 2019-05-09 Revance Therapeutics, Inc. Botulinum toxin formulations and methods of use thereof in plantar fasciitis with extended duration of effect
WO2019113133A1 (en) * 2017-12-04 2019-06-13 Revance Therapeutics, Inc. Injectable botulinum toxin formulations and methods of use thereof having high response rate and long effect duration
RU2741221C1 (ru) 2020-04-30 2021-01-22 Федеральное государственное автономное образовательное учреждение высшего образования "Крымский федеральный университет имени В.И. Вернадского" (ФГАОУ ВО "КФУ им. В.И. Вернадского") Способ комплексной реабилитации двигательной функции верхней конечности у больных детским церебральным параличом

Similar Documents

Publication Publication Date Title
JP2020520917A5 (https=)
RU2018118651A (ru) Композиции и способы терапии, связанной с фекальной микробиотой
JP2012532185A5 (https=)
HRP20191852T1 (hr) Polipeptidi
JP2015517488A5 (https=)
RU2013108248A (ru) Иммуногенные противовоспалительные композиции
JP2018531984A5 (https=)
JP2019520841A5 (https=)
JP2017523985A5 (https=)
JP2015518818A5 (https=)
JP2012176978A5 (https=)
JP2018502956A5 (https=)
JP2015529685A5 (https=)
JP2016518442A5 (https=)
JP2015510393A5 (https=)
FI3065763T4 (fi) Il-22-dimeerin käyttö lääkkeen valmistamisessa suonensisäistä antoa varten
RU2019141383A (ru) Способы лечения цервикальной дистонии
JP2017512194A5 (https=)
JP2014529399A5 (https=)
RU2015106742A (ru) Композиции, содержащие химерные молекулы ospa и способы их применения
Lin et al. Antimicrobial peptide-inspired antibacterial polymeric materials for biosafety
JP2020117504A5 (https=)
JP2013542196A5 (https=)
JP2018100243A5 (https=)
JP2016512247A5 (https=)